Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Etoposide Doxorubicin Cisplatin

Mixed Results for New Tx in Adrenal Cancer

Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy, but had a significantly higher response rate and progression-free survival (PFS), results of a large multicenter study showed.

Overall survival improved by almost 3 months with etoposide-doxorubicin-cisplatin (EDP) chemotherapy plus mitotane when compared with mitotane plus streptozocin, but… Mixed Results for New Tx in Adrenal Cancer   



chronic kidney disease33 - dyspareunia3 - prcc21 - fresenius1 - cmaj2 - fallopian tube2 - high glucose1 - neurological disorders1 - prostate cancer diagnosis1 - internal and external genitalia1 - archives of internal medicine2 - journal of the national cancer institute1 - urodynamic assessment5 - retinal hemorrhages1 - utero surgery1 - clinical trials1 - hyperuricemia1 - mutation1 - renal cancer2 - autoimmune kidney disorder1 - subacute1 - trisomy1 - statin drugs1 - urethral valve1 - pelvic irradiation1 - adrenocortical carcinoma1 - special la coke1 - obese kidney transplant recipients1 - artificial1 - systemic lupus erythematosus1 -